Last update Feb. 12, 2025

ATC B01AC: Antithrombotic agents: Platelet aggregation inhibitors

Clopidogrel (belonging to ATC B01AC: Antithrombotic agents: Platelet aggregation inhibitors):

Decreased level of risk

New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary., is now set to Safe product and/or breastfeeding is the best option.

Level of risk reviewed on Feb. 11, 2025

SAFE, BEST OPTION
FAIRLY SAFE
UNSAFE
VERY UNSAFE

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Groups related with ATC B01AC: Antithrombotic agents: Platelet aggregation inhibitors

Total visits

6,869

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM